Pediatric Neuroblastoma Treatment Market
1 Study Coverage
1.1 Pediatric Neuroblastoma Treatment Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Introduction
1.2 Global Pediatric Neuroblastoma Treatment Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size for the Year 2017-2028
1.2.2 Global Pediatric Neuroblastoma Treatment Market Size for the Year 2017-2028
1.3 Pediatric Neuroblastoma Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Pediatric Neuroblastoma Treatment in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Pediatric Neuroblastoma Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Pediatric Neuroblastoma Treatment Market Dynamics
1.4.1 Pediatric Neuroblastoma Treatment Industry Trends
1.4.2 Pediatric Neuroblastoma Treatment Market Drivers
1.4.3 Pediatric Neuroblastoma Treatment Market Challenges
1.4.4 Pediatric Neuroblastoma Treatment Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Pediatric Neuroblastoma Treatment by Type
2.1 Pediatric Neuroblastoma Treatment Market Segment by Type
2.1.1 Immunotherapy
2.1.2 Chemotherapy
2.1.3 Others
2.2 Global Pediatric Neuroblastoma Treatment Market Size by Type (2017, 2022 & 2028)
2.3 Global Pediatric Neuroblastoma Treatment Market Size by Type (2017-2028)
2.4 United States Pediatric Neuroblastoma Treatment Market Size by Type (2017, 2022 & 2028)
2.5 United States Pediatric Neuroblastoma Treatment Market Size by Type (2017-2028)
3 Pediatric Neuroblastoma Treatment by Application
3.1 Pediatric Neuroblastoma Treatment Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Pediatric Neuroblastoma Treatment Market Size by Application (2017, 2022 & 2028)
3.3 Global Pediatric Neuroblastoma Treatment Market Size by Application (2017-2028)
3.4 United States Pediatric Neuroblastoma Treatment Market Size by Application (2017, 2022 & 2028)
3.5 United States Pediatric Neuroblastoma Treatment Market Size by Application (2017-2028)
4 Global Pediatric Neuroblastoma Treatment Competitor Landscape by Company
4.1 Global Pediatric Neuroblastoma Treatment Market Size by Company
4.1.1 Top Global Pediatric Neuroblastoma Treatment Companies Ranked by Revenue (2021)
4.1.2 Global Pediatric Neuroblastoma Treatment Revenue by Player (2017-2022)
4.2 Global Pediatric Neuroblastoma Treatment Concentration Ratio (CR)
4.2.1 Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Pediatric Neuroblastoma Treatment in 2021
4.2.3 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pediatric Neuroblastoma Treatment Headquarters, Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Type
4.3.1 Global Pediatric Neuroblastoma Treatment Headquarters and Area Served
4.3.2 Global Pediatric Neuroblastoma Treatment Companies Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Pediatric Neuroblastoma Treatment Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Pediatric Neuroblastoma Treatment Market Size by Company
4.5.1 Top Pediatric Neuroblastoma Treatment Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pediatric Neuroblastoma Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Pediatric Neuroblastoma Treatment Market Size by Region
5.1 Global Pediatric Neuroblastoma Treatment Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pediatric Neuroblastoma Treatment Market Size by Region (2017-2028)
5.2.1 Global Pediatric Neuroblastoma Treatment Market Size by Region: 2017-2022
5.2.2 Global Pediatric Neuroblastoma Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.1.2 North America Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.3.2 Europe Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.4.2 Latin America Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pediatric Neuroblastoma Treatment Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pediatric Neuroblastoma Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 United Therapeutics
7.1.1 United Therapeutics Company Details
7.1.2 United Therapeutics Business Overview
7.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
7.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.1.5 United Therapeutics Recent Development
7.2 Apeiron Biologics
7.2.1 Apeiron Biologics Company Details
7.2.2 Apeiron Biologics Business Overview
7.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
7.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.2.5 Apeiron Biologics Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Details
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
7.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.3.5 Pfizer Recent Development
7.4 Bayer
7.4.1 Bayer Company Details
7.4.2 Bayer Business Overview
7.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
7.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.4.5 Bayer Recent Development
7.5 Baxter
7.5.1 Baxter Company Details
7.5.2 Baxter Business Overview
7.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
7.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.5.5 Baxter Recent Development
7.6 Cellectar Biosciences
7.6.1 Cellectar Biosciences Company Details
7.6.2 Cellectar Biosciences Business Overview
7.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
7.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.6.5 Cellectar Biosciences Recent Development
7.7 MacroGenics
7.7.1 MacroGenics Company Details
7.7.2 MacroGenics Business Overview
7.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
7.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022)
7.7.5 MacroGenics Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Pediatric Neuroblastoma Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Pediatric Neuroblastoma Treatment Market Trends
Table 3. Pediatric Neuroblastoma Treatment Market Drivers
Table 4. Pediatric Neuroblastoma Treatment Market Challenges
Table 5. Pediatric Neuroblastoma Treatment Market Restraints
Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pediatric Neuroblastoma Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pediatric Neuroblastoma Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pediatric Neuroblastoma Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pediatric Neuroblastoma Treatment Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Pediatric Neuroblastoma Treatment Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Pediatric Neuroblastoma Treatment Revenue Share by Player, 2017-2022
Table 13. Global Pediatric Neuroblastoma Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Neuroblastoma Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2021)
Table 15. Top Players of Pediatric Neuroblastoma Treatment in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Pediatric Neuroblastoma Treatment Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Pediatric Neuroblastoma Treatment Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Pediatric Neuroblastoma Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Pediatric Neuroblastoma Treatment Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Pediatric Neuroblastoma Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Pediatric Neuroblastoma Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Pediatric Neuroblastoma Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Pediatric Neuroblastoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Pediatric Neuroblastoma Treatment Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Pediatric Neuroblastoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Pediatric Neuroblastoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Pediatric Neuroblastoma Treatment Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. United Therapeutics Company Details
Table 31. United Therapeutics Business Overview
Table 32. United Therapeutics Pediatric Neuroblastoma Treatment Product
Table 33. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 34. United Therapeutics Recent Development
Table 35. Apeiron Biologics Company Details
Table 36. Apeiron Biologics Business Overview
Table 37. Apeiron Biologics Pediatric Neuroblastoma Treatment Product
Table 38. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 39. Apeiron Biologics Recent Development
Table 40. Pfizer Company Details
Table 41. Pfizer Business Overview
Table 42. Pfizer Pediatric Neuroblastoma Treatment Product
Table 43. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 44. Pfizer Recent Development
Table 45. Bayer Company Details
Table 46. Bayer Business Overview
Table 47. Bayer Pediatric Neuroblastoma Treatment Product
Table 48. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 49. Bayer Recent Development
Table 50. Baxter Company Details
Table 51. Baxter Business Overview
Table 52. Baxter Pediatric Neuroblastoma Treatment Product
Table 53. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 54. Baxter Recent Development
Table 55. Cellectar Biosciences Company Details
Table 56. Cellectar Biosciences Business Overview
Table 57. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product
Table 58. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 59. Cellectar Biosciences Recent Development
Table 60. MacroGenics Company Details
Table 61. MacroGenics Business Overview
Table 62. MacroGenics Pediatric Neuroblastoma Treatment Product
Table 63. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2017-2022) & (US$ Million)
Table 64. MacroGenics Recent Development
Table 65. Research Programs/Design for This Report
Table 66. Key Data Information from Secondary Sources
Table 67. Key Data Information from Primary Sources
List of Figures
Figure 1. Pediatric Neuroblastoma Treatment Product Picture
Figure 2. Global Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pediatric Neuroblastoma Treatment Market Size 2017-2028 (US$ Million)
Figure 4. United States Pediatric Neuroblastoma Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Pediatric Neuroblastoma Treatment Market Size 2017-2028 (US$ Million)
Figure 6. United States Pediatric Neuroblastoma Treatment Market Share in Global 2017-2028
Figure 7. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 8. Product Picture of Immunotherapy
Figure 9. Product Picture of Chemotherapy
Figure 10. Product Picture of Others
Figure 11. Global Pediatric Neuroblastoma Treatment Market Share by Type in 2022 & 2028
Figure 12. Global Pediatric Neuroblastoma Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 13. Global Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
Figure 14. United States Pediatric Neuroblastoma Treatment Market Share by Type in 2022 & 2028
Figure 15. United States Pediatric Neuroblastoma Treatment Market Size by Type (2017-2028) & (US$ Million)
Figure 16. United States Pediatric Neuroblastoma Treatment Market Share by Type (2017-2028)
Figure 17. Product Picture of Hospitals
Figure 18. Product Picture of Clinics
Figure 19. Product Picture of Others
Figure 20. Global Pediatric Neuroblastoma Treatment Market Share by Application in 2022 & 2028
Figure 21. Global Pediatric Neuroblastoma Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 22. Global Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
Figure 23. United States Pediatric Neuroblastoma Treatment Market Share by Application in 2022 & 2028
Figure 24. United States Pediatric Neuroblastoma Treatment Market Size by Application (2017-2028) & (US$ Million)
Figure 25. United States Pediatric Neuroblastoma Treatment Market Share by Application (2017-2028)
Figure 26. North America Pediatric Neuroblastoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 27. U.S. Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 28. Canada Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 29. Europe Pediatric Neuroblastoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 30. Germany Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 31. France Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 32. U.K. Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Italy Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Russia Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 36. China Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. Japan Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. South Korea Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. India Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Australia Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 41. Taiwan Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Indonesia Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. Thailand Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. Malaysia Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Philippines Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Latin America Pediatric Neuroblastoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 47. Mexico Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Brazil Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Argentina Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size Growth Rate 2017-2028 (US$ Million)
Figure 51. Turkey Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. UAE Pediatric Neuroblastoma Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 55. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 57. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 58. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 59. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 60. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Industry Market Size
